bioCSL has commenced distribution of Immucor’s Capture technology platform and reagents in Australia and New Zealand. Capture is antibody detection technology used in the crossmatching of blood used for transfusion.
The technology is said to work differently from the techniques commonly used in Australia, delivering high levels of specificity and potentially reducing both the need for additional testing and delays for patients awaiting a blood transfusion. The product has a high degree of sensitivity for detection of clinically significant antibodies, providing confidence and accuracy in pre‐transfusion and prenatal screening.
Phone: 1300 369 559
BioActs Fluorescent FSD Fluor Dyes
The FSD Fluor series is a panel of fluorescent dyes with good fluorescence intensity and a high...
Ansell BioClean PPE range
BioClean products are part of Ansell Limited's Life Sciences Solutions portfolio, offering a...
Larodan research-grade glycerides
Larodan develops a comprehensive range of research-grade lipids for use as analytical standards...
